Description: Prana Biotechnology is developing first-in-class therapies to treat neurodegenerative disease.
Home Page: alteritytherapeutics.com
460 Bourke Street
Melbourne,
VIC
3000
Australia
Phone:
61 3 9349 4906
Officers
| Name | Title |
|---|---|
| Mr. Geoffrey Paul Kempler B.Sc, B.Sc. | Co-Founder & Non-Exec. Chairman |
| Dr. David A. Stamler M.D. | Chief Exec. Officer |
| Ms. Kathryn J. E. Andrews | Chief Financial Officer |
| Dr. Rudolph Emile Tanzi Ph.D. | Chief Scientific Advisor and Member of R&D Advisory Board |
| Dr. Steven D. Targum | Chief Medical Advisor |
| Dr. Robert Cherny | Head of Research |
| Mr. Phillip Allen Hains BBus(Acc), CA, MBA | Company Sec. |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.666 |
| Price-to-Sales TTM: | 3.124 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 12 |